List of Excipients in Branded Drug ACID RELIEF

Generic Drugs Containing ACID RELIEF

Company	Ingredient	NDC	Excipient
Rite Aid Corporation	famotidine	11822-1014	CELLULOSE, MICROCRYSTALLINE
Rite Aid Corporation	famotidine	11822-1014	CROSCARMELLOSE SODIUM
Rite Aid Corporation	famotidine	11822-1014	FD&C BLUE NO. 1
Rite Aid Corporation	famotidine	11822-1014	HYPROMELLOSE
Rite Aid Corporation	famotidine	11822-1014	LACTOSE MONOHYDRATE

What are the Most Frequently-Used Excipients in ACID RELIEF?

# Of NDCs	Excipient
5	CARNAUBA WAX
9	CELLULOSE, MICROCRYSTALLINE
5	CROSCARMELLOSE SODIUM
2	D&C YELLOW NO. 10
2	FD&C BLUE NO. 1

Excipient Strategy and Commercial Opportunities for Acid Relief

Last updated: March 3, 2026

What are the primary excipient considerations in acid relief formulations?

Excipient selection in acid relief drugs impacts efficacy, stability, patient compliance, and manufacturing efficiency. Key excipients include antacid agents, buffers, binders, disintegrants, and flavoring agents.

Core Excipients in Acid Relief Drugs

• Antacids: Aluminum hydroxide, magnesium hydroxide, calcium carbonate. These neutralize gastric acid directly.
• Buffers: Sodium bicarbonate stabilizes pH and provides rapid relief.
• Disintegrants: Crospovidone and sodium starch glycolate facilitate tablet breakdown.
• Binders: Povidone, hypromellose ensure tablet cohesion and stability.
• Flavoring agents: Mint, citrus oils improve palatability.

Formulation Considerations

• pH stability: Excipients influence bioavailability and stability.
• Drug-excipient compatibility: Prevent interactions that affect potency.
• Palatability: Flavoring and sweeteners increase patient compliance.
• Manufacturing: Excipients affect tablet compressibility, solubility, and shelf-life.

What is the commercial potential of excipient strategies in acid relief products?

Market growth driven by increased prevalence of gastroesophageal reflux disease (GERD) and acid indigestion cases supports expanding opportunities.

Market Dynamics

• The global antacid market was valued at approximately USD 1.2 billion in 2021 and is projected to grow at a CAGR of 4.2%, reaching USD 1.6 billion by 2028 [1].
• Major players include Johnson & Johnson, GlaxoSmithKline, and Novartis, with innovation in formulations serving as competitive differentiators.

Opportunities

• Enhanced formulations: Incorporation of faster-dissolving excipients improves onset of action.
• Novel excipient use: Adding prebiotics or probiotics as adjuncts for holistic digestive health.
• Pediatric and geriatric formulations: Tailoring excipient profiles to address age-specific tolerances.
• Low excipient or excipient-free formats: Addressing sensitivities, increasing market share.

Formulation Innovations

• Development of chewable tablets with taste-masking agents.
• Use of nanotechnology to enhance excipient-drug interactions.
• Creating multi-functional formulations combining acid neutralization with mucosal protection.

How can companies capitalize on excipient innovation?

• Intellectual property (IP): Patents on novel excipient combinations or delivery systems.
• Regulatory pathways: Fast-tracking approval through clear safety profiles of excipients.
• Strategic partnerships: Collaborating with excipient suppliers for custom development.
• Cost efficiency: Developing scalable processes that reduce manufacturing expenses.

What are the risks associated with excipient strategies?

• Regulatory hurdles: Stringent safety and compatibility assessments.
• Supply chain disruptions: Reliance on specific excipients may create vulnerabilities.
• Variability: Batch-to-batch consistency becomes critical for consistent therapeutic outcomes.
• Patient sensitivities: Potential for allergic reactions limits excipient choices.

---

Key Takeaways

• Excipient selection critically influences the performance and marketability of acid relief products.
• Market expansion hinges on formulation innovation, including faster relief and patient-specific formulations.
• Companies can leverage new excipient combinations, IP rights, and strategic partnerships to secure competitive advantages.
• Balancing efficacy, safety, and manufacturing efficiency remains essential amid regulatory and supply chain risks.

---

FAQs

What are the most common excipients in OTC acid relief medications?
Antacids (aluminum hydroxide, magnesium hydroxide), buffers (sodium bicarbonate), flavoring agents, and binders (povidone) are typical.

How do excipients affect drug stability in acid relief formulations?
They influence pH stability, prevent degradation reactions, and ensure consistent release profiles.

Are there regulatory restrictions on excipient use?
Yes. Regulatory agencies like the FDA require safety data, compatibility assessments, and batch consistency for excipients.

Can innovative excipients improve patient adherence?
Yes. Taste-masking agents and formulations like chewables or liquids enhance compliance.

What future trends could impact excipient strategies?
Personalized medicine, incorporation of probiotics, nanotechnology, and clean-label formulations drive future excipient innovation.

---

References

[1] MarketsandMarkets. (2022). Antacid Market by Product, Distribution Channel, and Region — Global Forecast to 2028.